|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Graft Rejection | |||||
| 2 | Interventions listed in this trial | ||||
| Alemtuzumab | |||||
| Anti-Thymocyte Globulin | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Antilymphocyte Serum | |||||
| Pancrelipase | |||||
| 4 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Gastrointestinal Agents | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| Wake Forest University Baptist Medical Center | |||||